Anonymous
Guest
Anonymous
Guest
You know the future of the pharmaceutical rep is dim when Merck decides to move away from hiring reps in a developing market. Stick a fork in us.
You know the future of the pharmaceutical rep is dim when Merck decides to move away from hiring reps in a developing market. Stick a fork in us.
You know the future of the pharmaceutical rep is dim when Merck decides to move away from hiring reps in a developing market. Stick a fork in us.
Care to reference what you stated? Is it due to nationalism as many countries only allow partnership with a foreign company but not operating all by itself? Change in the local market? I read they are hiring physicians to be reps in China because they can make more money than working as a government doctor.
If you care to read articles related to what you said in its entirety you would notice Merck is shifting away hiring its own reps and trying to promote products through local partners. This is very common in Japan and other countries too. You know Astra asked Merck to introduce and promote Prilosec in the United States, right? You know Yamanouchi used to sell the bulk ingredients to Merck to sell as Pepcid in this country, right? You know Boots in England licensed ibuprofen to Upjohn in the States to sell as Motrin, right?
Don't read too much gloom and doom into everything.
You know the future of the pharmaceutical rep is dim when Merck decides to move away from hiring reps in a developing market. Stick a fork in us.